Correction: The association between dietary quality scores with C-reactive protein and novel biomarkers of inflammation platelet-activating factor and lipoprotein-associated phospholipase A2: a cross-sectional study (Nutrition & Metabolism, (2023), 20, 1, (38), 10.1186/s12986-023-00756-x)

Following the publication of the original article [1], the authors identified errors in the description of the score range of the Vegetarian Lifestyle Index in Table 1 and in the Methods section. The updated sentence and Table 1 are given below, and the changes have been highlighted in bold typeface. The sentence currently reads: The total vegetarian score was calculated by summing all of the points from each respective section to generate a composite score ranging in values from 0 to 80. The sentence should read: The total vegetarian score was calculated by summing all of the points from each respective section to generate a composite score ranging in values from 0 to 14. The incorrect Table 1 is: (Table presented.) Demographic and clinical characteristics of study subjects Characteristics Mean ± SD or N (%) or Median (IQR range) Mean ± SD or N (%) or Median (IQR range) Total n = 100 Male n = 31 Female n = 69 High risk of CVD n = 68 Low risk of CVD n = 32 Age, yearsb 49 ± 13 46 ± 13 50 ± 13 0.120 53 ± 13 38 ± 14 Race, Caucasian n (%) 92 (92) 25 (86) 67 (94) − 65 (96) 27 (84) – Male n (%) 31 (31) − 21 (31) 10 (31) – BMI, kg/m2b 28.3 ± 6.5 27.41 ± 5.0 28.65 ± 7.2 0.729 30.65 ± 6.4 23.19 ± 2.7 Waist Circumference (cm) Umbilicusb 95.8 ± 6.7 95.99 ± 12.60 95.70 ± 18.40 0.526 102.36 ± 15.40 81.83 ± 9.15 Type 2 Diabetes diagnosis % 4 (4) 3 (10) 1 (1) – 4 (6) 0 (0) – Physical Activity METs tertiles 1.41 ± 0.65 1.61 ± 0.72 1.32 ± 0.83 0.193 1.28 ± . 84 1.69 ± . 65 0.193 n (%) low PA 20 (20) 4 (13) 16 (23) – 17 (25) 3 (9) – n (%) medium PA 19 (19) 4 (13) 15 (22) – 15 (22) 4 (13) – n (%) high PA 61 (61) 23 (74) 38 (55) – 36 (53) 25 (78) – PAF ng/mLb 7.96 (3.89 – 16.77) 9.95 (4.31 – 15.33) 6.45 (3.81 – 18.90) 0.814 4.84 (3.24 – 14.57) 13.27 (9.59 – 21.63) Lp-PLA2 nmol/min/mL 14.91 ± 4.29 16.98 ± 4.90 13.98 ± 3.65 15.30 ± 4.42 14.09 ± 3.94 0.19 hsCRP mg/Lb,c 0.96 (0.49 – 2.98) 0.93 (0.41–2.1) 1.1 (0.5–3.14) 0.392 1.79 (0.64 – 3.80) 0.56 (0.22 – 1.01) DASH Index (0–80)d 43.86 ± 8.59 43.00 ± 8.44 44.25 ± 8.69 0.505 42.10 ± 8.68 47.59 ± 7.19 Vegetarian Lifestyle Index (0–15)d 7.64 ± 1.58 7.08 ± 1.29 7.89 ± 1.65 7.40 ± 1.53 8.15 ± 1.58 HEIFA Score (0–100)d 60.04 ± 11.61 60.84 ± 11.73 59.68 ± 11.63 0.647 57.74 ± 11.28 64.94 ± 10.92 MEDAS Score (0–14)d 6.45 ± 2.30 6.45 ± 2.43 6.45 ± 2.26 0.996 6.07 ± 2.09 7.25 ± 2.55 erMedDiet Score (0–17)d 8.30 ± 2.25 8.10 ± 2.12 8.39 ± 2.31 0.547 8.03 ± 2.02 8.88 ± 2.61 0.112 aIndependent T-test performed P < 0.05 represents significant difference b Mann Whitney U test performed P < 0.05 represents significant difference, c n = 99, d Higher scores indicate greater adherence BMI, body mass index; DASH, Dietary Approach to Stop Hypertension; erMedDIET, Predimed-Plus Diet Score; HEIFA, Healthy Eating Index for Australian Adults; hsCRP, high-sensitivity c reactive protein; Lp-PLA2, lipoprotein-associated phospholipase A2; mg/L, MEDAS, Mediterranean Diet Adherence Screener; milligrams per litre; ng/L, nanograms per litre; nmol/min/mL, nanomoles per min per millilitre; PA, physical activity; PAF, platelet activating factor; SBP, systolic blood pressure; SD, standard deviation Bold values indicate statistical significance at p <.05 The correct Table 1 is: (Table presented.) Demographic and clinical characteristics of study subjects Characteristics Mean ± SD or N (%) or Median (IQR range) P valuea Mean ± SD or N (%) or Median (IQR range) P valuea Total n = 100 Male n = 31 Female n = 69 High Risk of CVD n = 68 Low Risk of CVD n = 32 Age, yearsb 49 ± 13 46 ± 13 50 ± 13 120 53 ± 13 38 ± 14 Race, Caucasian n (%) 92 (92) 25 (86) 67 (94) 65 (96) 27 (84) Male n (%) 21 (31) 10 (31) BMI, kg/m2b 28.3 ± 6.5 27.41 ± 5.0 28.65 ± 7.2 0.729 30.65 ± 6.4 23.19 ± 2.7 Waist Circumference (cm) Umbilicusb 95.8 ± 6.7 95.99 ± 12.60 95.70 ± 18.40 0.526 102.36 ± 15.40 81.83 ± 9.15 Type 2 Diabetes diagnosis % 4 (4) 3 (10) 1 (1) – 4 (6) 0 (0) – Physical Activity METs tertiles 1.41 ± 0.65 1.61 ± 0.72 1.32 ± 0.83 0.193 1.28 ± . 84 1.69 ± . 65 0.193 n (%) low PA 20 (20) 4 (13) 16 (23) – 17 (25) 3 (9) – n (%) medium PA 19 (19) 4 (13) 15 (22) – 15 (22) 4 (13) – n (%) high PA 61 (61) 23 (74) 38 (55) – 36 (53) 25 (78) – PAF ng/mLb 7.96 (3.89–16.77) 9.95 (4.31–15.33) 6.45 (3.81–18.90) 0.814 4.84 (3.24–14.57) 13.27 (9.59–21.63) Lp-PLA2 nmol/min/mL 14.91 ± 4.29 16.98 ± 4.90 13.98 ± 3.65 15.30 ± 4.42 14.09 ± 3.94 0.19 hsCRP mg/Lb,c 0.96 (0.49–2.98) 0.93 (0.41–2.1) 1.1 (0.5–3.14) 0.392 1.79 (0.64–3.80) 0.56 (0.22–1.01) DASH Index (0–80) 43.86 ± 8.59 43.00 ± 8.44 44.25 ± 8.69 0.505 42.10 ± 8.68 47.59 ± 7.19 Vegetarian Lifestyle Index (0–14) 7.64 ± 1.58 7.08 ± 1.29 7.89 ± 1.65 7.40 ± 1.53 8.15 ± 1.58 HEIFA Score (0–100) 60.04 ± 11.61 60.84 ± 11.73 59.68 ± 11.63 0.647 57.74 ± 11.28 64.94 ± 10.92 MEDAS Score (0–14) 6.45 ± 2.30 6.45 ± 2.43 6.45 ± 2.26 0.996 6.07 ± 2.09 7.25 ± 2.55 erMedDiet Score (0–17) 8.30 ± 2.25 8.10 ± 2.12 8.39 ± 2.31 0.547 8.03 ± 2.02 8.88 ± 2.61 0.112 BMI body mass index, DASH Dietary Approach to Stop Hypertension, erMedDIET Predimed-Plus Diet Score, HEIFA Healthy Eating Index for Australian Adults, hsCRP high-sensitivity c reactive protein, Lp-PLA2 lipoprotein-associated phospholipase A2, mg/L, MEDAS, Mediterranean Diet Adherence Screener; milligrams per litre, ng/L, nanograms per litre, nmol/min/mL nanomoles per min per millilitre, PA physical activity, PAF platelet activating factor, SBP systolic blood pressure, SD standard deviation aIndependent T-test performed P < 0.05 represents significant difference bMann Whitney U test performed P < 0.05 represents significant difference cn = 99 The original article [1] has been corrected. © 2023, The Author(s).